Cerebral Hypoxia Clinical Trials

Find Cerebral Hypoxia Clinical Trials Near You

Effect of Hypoxic Conditioning on Cerebrovascular Health in the Elderly

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

In line with the ever-growing aging of Western populations, the development of preventive strategies to slow down the effects of aging on cardiovascular health represents a major challenge in order to preserve functional capacities and a sufficient quality of life in the elderly. The alteration of vascular function (at the cerebral and systemic level) with aging is an important feature in the clinical picture including a decrease in physical and cognitive capacities. Although physical activity is recognized as an essential means of combating the effects of aging, optimizing its effects by defining the most effective strategies of practice remains a key objective. Offering alternative interventions to exercise training is also necessary for people who are unwilling or unable to engage in a physical activity program. In this context, hypoxic conditioning, alone or in conjunction with rehabilitative exercise training, is a new therapeutic modality with strong preclinical validity, in particular from a cardiovascular standpoint, and used in other pathologies to improve cardiovascular function and exercise performance and quality of life. Our aim is, therefore, to investigate the effect of hypoxic conditioning (alone or in conjunction with exercise training) on cerebrovascular health in the elderly.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 60
Maximum Age: 80
Healthy Volunteers: t
View:

• 60 to 80 years of age;

• Being physically inactive (less than 150 min/week of moderate to intense physical activity);

• No chronic cardiovascular, respiratory, metabolic or neuromuscular disease counterindicating an exercise training or hypoxic conditioning program;

• Health coverage;

• Being able to provide written fully informed consent.

Locations
Other Locations
France
CHU Grenoble Alpes
RECRUITING
La Tronche
Contact Information
Primary
Stéphane Doutreleau, MD, PhD
sdoutreleau@chu-grenoble.fr
+33476767773
Backup
Samuel Vergès, PhD
sverges@chu-grenoble.fr
+33476766860
Time Frame
Start Date: 2021-10-13
Estimated Completion Date: 2026-09
Participants
Target number of participants: 64
Treatments
Experimental: Hypoxia - Rest
Sessions of intermittent hypoxia at rest; 3 sessions/week; 8 weeks. To be compared with the placebo (normoxia) group at rest.
Placebo_comparator: Normoxia - Rest
Sessions of normoxia at rest; 3 sessions/week; 8 weeks.
Experimental: Hypoxia - Exercise
Sessions of exercise training under hypoxia; 3 sessions/week; 8 weeks. To be compared with the placebo (exercise under normoxia) group.
Active_comparator: Normoxia - Exercise
Sessions of exercise training under hypoxia; 3 sessions/week; 8 weeks.
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Grenoble

This content was sourced from clinicaltrials.gov